As per Future Market Insights, the osteoarthritis gene therapy market is forecasted to attain a valuation of US$ 7.5 billion by 2023-end. Global demand for osteoarthritis gene therapy is expected to soar at a CAGR of 7.9% to US$ 16 billion in 2033, supported by:
| Data Points | Key Statistics |
| Expected Market Value in 2023 | US$ 7.5 billion |
| Projected Market Value in 2033 | US$ 16 billion |
| Growth Rate (2023 to 2033) | 7.9% CAGR |
The demand outlook is anticipated to develop steadfast during the forecast period.
The providers of this therapy are expected to go through a high demand phase that would offer them various opportunities for progress.
The development of the osteoarthritis gene therapy market in Europe is gaining momentum, with a focus on improving patient outcomes and addressing the unmet medical needs of those suffering from osteoarthritis. The increasing prevalence of the disease, coupled with advancements in gene editing and delivery technologies, is driving growth in the field.
Pharmaceutical companies are also investing heavily in the development of new treatments, with several clinical trials underway in the region. With the increasing awareness of the potential of gene therapy to address the underlying causes of osteoarthritis, the market is expected to continue to grow in Europe in the coming years, providing new and innovative treatments for patients.
Hospitals are the most lucrative end-user of the osteoarthritis gene therapy market due to their role in delivering advanced medical treatments to patients. As the demand for effective treatments for osteoarthritis increases, hospitals are at the forefront of providing gene therapy as a potential solution. Numerous hospitals have a strong financial incentive to offer the latest treatments, as they can charge premium prices for these innovative therapies.
Osteoarthritis (OA) is one of the leading cause of disability in the western world. According to the Osteoarthritis Foundation International, the prevalence of OA is approximately 500 million people, globally.
The disease is characterized by being incurable, incurring immense treatment cost but responding very poorly to the treatment. The fact that OA is a debilitating disease and gene therapy provides a hope for treatment and pain reduction, there is a very high demand for this therapy, globally. This is one of the major driver for this market.
The presence of a large number of geriatric and target patients, as well as improved healthcare infrastructure in several countries in the Asia-Pacific region, is expected to open up market opportunities during the forecast period.
A novel approach to gene editing using the CRISPR / Ca9 system bypasses disease-causing mutations in a gene, providing treatment for single-gene-related genetic diseases such as cystic fibrosis, certain types of sickle cell anemia and other rare diseases.
The CRISPR / Ca9 system has created promising new therapies for genes that can target and correct disease-causing mutations in a gene. In this process, Cas9 - a bacterial protein - cuts DNA at a specific location where it can edit, trim the genetic sequence, or insert a new sequence before repairing the DNA.
The Osteoarthritis gene therapy market in the USA and Canada regions is expected to be slightly affected due to the COVID-19 pandemic. The demand is supposed to show slight growth due to the government investments in various R&D activities in cell based research.
Since the gene therapy can be personalized for every patient’s need, this is anticipated to drive the demand outlook in these regions.
The European region dominated osteoarthritis gene therapy market during the year 2020. This can be attributed to various reasons that contribute to the demand of this therapy such as rising prevalence of osteoarthritis cases in the region, increased geriatric population due to increased access to advanced medical care and rising obesity rates in various countries of Europe.
The key players in osteoarthritis gene therapy demand outlook are
On 19th November 2018, Mundipharma signed a multi-year agreement with Kolon Life Sciences, where they secured the exclusive rights for Invossa osteoarthritis therapy in Japan. This collaboration was intended to ensure that all the patients suffering from osteoarthritis in Japan had access to latest breakthrough treatments like Invossa.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.
The report also maps the qualitative impact of various market factors on market segments and geographies.
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Gene Therapy in CNS Disorder Market Analysis by Indication, Type, End User, and Region through 2035
Cancer Gene Therapy Market Overview – Trends & Future Outlook 2024-2034
Retinal Gene Therapy Market – Trends & Forecast 2025 to 2035
Cell and Gene Therapy Clinical Trial Market Size and Share Forecast Outlook 2025 to 2035
Cell and Gene Therapy Manufacturing Market - Growth & Trends 2025 to 2035
Protein Degeneration Therapy Market
Rare Disease Gene Therapy Market
Generator Bushing Market Size and Share Forecast Outlook 2025 to 2035
Gene Editing Tool Market Forecast and Outlook 2025 to 2035
Genetic Analyzers Market Size and Share Forecast Outlook 2025 to 2035
General Intelligent Decision-Making Service Market Size and Share Forecast Outlook 2025 to 2035
General Equipment Rental Services Market Size and Share Forecast Outlook 2025 to 2035
General Purpose DC Contactor Market Size and Share Forecast Outlook 2025 to 2035
Generative AI in Packaging Market Size and Share Forecast Outlook 2025 to 2035
Generative AI In Chemical Market Size and Share Forecast Outlook 2025 to 2035
Generator Sales Market Size and Share Forecast Outlook 2025 to 2035
Generic Injectable Market Report - Growth, Demand & Forecast 2025 to 2035
Generator Sets Market Size and Share Forecast Outlook 2025 to 2035
Generative AI in Logistics Market Size and Share Forecast Outlook 2025 to 2035
Gene Synthesis Market Growth – Trends & Forecast 2025 to 2035
Osteoarthritis Gene Therapy Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
